Sign In  |  Register  |  About Sunnyvale  |  Contact Us

Sunnyvale, CA
September 01, 2020 10:10am
7-Day Forecast | Traffic

  • Search Hotels in Sunnyvale

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Immunic, Inc. - Common Stock (NQ: IMUX )

0.9860 +0.0330 (+3.46%)
Streaming Delayed Price Updated: 9:54 AM EST, Jan 21, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Immunic, Inc. - Common Stock

< Previous 1 2 3 4 5 6 Next >
Why Immunic Shares Are Trading Higher By Around 13%; Here Are 20 Stocks Moving Premarket
Gainers SuperCom Ltd. (NASDAQ: SPCB) shares rose 78.4% to $0.6425 in pre-market trading, after falling 13% on Monday. 
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
It's time to dive into the biggest pre-market stock movers with all the most recent news moving shares on Tuesday morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Immunic Inc eyeing "big step" for multiple sclerosis patients
--News Direct-- 
Via News Direct
Immunic Inc set to bring relief with encouraging results
Immunic Inc set to bring relief with encouraging results 
Via News Direct
Immunic Inc set to bring relief with encouraging results
Dr Daniel Vitt, CEO of Immunic Inc (NASDAQ:IMUX), discusses the company's encouraging first-quarter performance with Proactive. 
Via TheNewswire.com
Recap: Immunic Q1 Earnings
Via Benzinga
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
--News Direct-- 
Via News Direct
Immunic CEO hails "great day" after completing IMU-838 phase 2 trial enrolment
Immunic Inc (NASDAQ:IMUX) President and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive after the biotechnology company announced the completion of the enrolment of its phase 2 CALLIPER trial... 
Via TheNewswire.com
Immunic CEO says Q2 results "couldn't be better"
--News Direct-- 
Via News Direct
Immunic CEO says Q2 results "couldn't be better"
Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt speaks to Thomas Warner from Proactive following the release of the Munich-based biotechnology company's second-quarter financial results and... 
Via TheNewswire.com
Immunic Inc eyeing "big step" for multiple sclerosis patients
Immunic Inc (NASDAQ:IMUX) president and CEO Dr Daniel Vitt joined Thomas Warner from Proactive ahead of World Brain Day to provide an update on the biotechnology company's novel multiple sclerosis (MS)... 
Via TheNewswire.com
Why Is Immunic (IMUX) Stock Up 23% Today?
Immunic (IMUX) stock is getting a boost on Wednesday after the company released results from its Phase 2 CALDOSE-1 Trial. 
Via InvestorPlace
Preview: Immunic's Earnings
Via Benzinga
Immunic Touts Positive Vidofludimus Calcium Data In Multiple Sclerosis Candidate
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
Immunic IMU-856 trial data "clearly goes beyond" initial expectations 
Via News Direct
Immunic IMU-856 trial data "clearly goes beyond" initial expectations
Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Thomas Warner from Proactive after releasing new clinical trial data for the biotechnology company's IMU-856 molecule, which is aimed at... 
Via TheNewswire.com
Immunic gets a "positive surprise" from lead asset trial
Immunic Inc (NASDAQ:IMUX) CEO Dr. Daniel Vitt speaks to Proactive following the release of data from the maintenance phase of its phase 2b CALDOSE-1 trial of lead asset vidofludimus calcium (IMU-838)... 
Via TheNewswire.com
Immunic gets a "positive surprise" from lead asset trial
Immunic gets a "positive surprise" from lead asset trial 
Via News Direct
Why Kura Sushi Shares Are Trading Lower By Around 9%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Gainers Nuburu, Inc. (NYSE: BURU) shares jumped 104% to $5.55 after the company announced it has been selected by the U.S. Department of Defense for a position on the multiple award Indefinite... 
Via Benzinga
After Positive Data In Ulcerative Colitis Study, Immunic Prioritizes Vidofludimus Calcium Program With One More Candidate
Via Benzinga
Why Is Nuvve (NVVE) Stock Down 14% Today?
Nuvve (NVVE) stock is down on Wednesday after the vehicle-to-grid technology company's shares underwent a rally yesterday. 
Via InvestorPlace
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why Is Secoo (SECO) Stock Down 16% Today?
Secoo (SECO) stock is retreating on Wednesday after the Chinese products and services company saw a massive rally on Tuesday. 
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
We're starting off Wednesday with a breakdown of the biggest pre-market stock movers traders need to know about this morning! 
Via InvestorPlace
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
BARK And 3 Other Stocks Under $2 Insiders Are Aggressively Buying
The Dow Jones closed higher by more than 150 points on Friday. Investors, meanwhile, focused on some notable insider trades. When insiders purchase or sell shares, it indicates their confidence or... 
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 Sunnyvale.com & California Media Partners, LLC. All rights reserved.